U.S. Home Infusion Therapy Market is Anticipated to Reach Around USD 39.7 Billion by 2032

Comments · 115 Views

United States home infusion therapy market size reached US$ 19.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 39.7 Billion by 2032, exhibiting a growth rate (CAGR) of 7.90% during 2024-2032.

United States Home Infusion Therapy Market Overview

Market Size in 2023: USD 19.7 Billion

Market Forecast in 2032: USD 39.7 Billion

Market Growth Rate: 7.90% (2024-2032)

According to the latest report by IMARC Group, The U.S. home infusion therapy market size market size reached USD 19.7 Billion in 2023. Looking forward, expects the market to reach USD 39.7 Billion by 2032, exhibiting a growth rate (CAGR) of 7.90% during 2024-2032. The market is expanding rapidly, driven by advancements in technology and the growing focus on home-based healthcare. This growth is fueled by the increasing demand for convenient and cost-effective treatment options, and the rising prevalence of chronic diseases requiring long-term infusion therapy.

United States Home Infusion Therapy Industry Trends and Drivers:

The United States home infusion therapy market is experiencing robust growth, driven by expanding healthcare needs and demographic shifts. With an increasing geriatric population and a rise in chronic conditions such as diabetes, cancer, and immune disorders, there is a growing demand for home-based care solutions, including infusion therapy. This has heightened the adoption of home infusion therapy, as it allows patients to receive treatment in the comfort of their own homes, reducing the need for hospital visits and improving overall patient convenience.

Moreover, the cost-effectiveness of home-based care, compared to extended hospital stays, is also a key factor facilitating industry expansion. Additionally, efforts by healthcare providers and insurance companies to reduce healthcare costs and alleviate the burden on hospitals are contributing substantially to the growth of the home infusion therapy market. By shifting treatment to the home, healthcare systems are able to free up hospital resources and offer patients a more personalized care approach. This shift is particularly beneficial for patients with long-term conditions that require frequent infusion treatments, such as antibiotics, pain management, and chemotherapy.

Key trends in the United States home infusion therapy market include technological innovation and the integration of remote monitoring solutions. Healthcare providers are increasingly incorporating advanced digital tools, such as telemedicine and remote monitoring devices, to track patient progress and ensure safe and effective administration of infusion therapies. This shift toward connected healthcare enables real-time data collection and enhances communication between patients and healthcare professionals, improving patient outcomes.

Moreover, the demand for more convenient, patient-friendly solutions has also led to the development of portable and user-friendly infusion devices, making home care more accessible. Consequently, the rising focus on personalized care and patient comfort is a significant growth-inducing factor. Home infusion therapy provides an alternative for patients who prefer to avoid frequent hospital or clinic visits, particularly amid concerns about infections, including during the COVID-19 pandemic. This has further increased the adoption of home-based treatments as patients seek safer environments for their care.

Furthermore, the pandemic has heightened the trend toward decentralized healthcare, with a rising demand for flexible treatment options that reduce the need for in-person visits. Additionally, advancements in medical devices and infusion pumps are enhancing the safety and efficiency of home infusion therapy, encouraging widespread adoption of this care model.

United States Home Infusion Therapy Industry Segmentation:

The report has segmented the market into the following categories:

Product Insights:

  • Infusion Pumps
    • Elastomeric
    • Electromechanical
    • Gravity
    • Others
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors

Application Insights:

  • Anti-Infective
  • Endocrinology
    • Diabetes
    • Others
  • Hydration Therapy
    • Athletes
    • Others
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals     
  • Others

Regional Insights:

  • Northeast
  • Midwest
  • South
  • West

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Key highlights of the Report:

  • Market Performance (2018-2023)
  • Market Outlook (2024-2032)
  • COVID-19 Impact on the Market
  • Porter’s Five Forces Analysis
  • Strategic Recommendations
  • Historical, Current and Future Market Trends
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Structure of the Market
  • Value Chain Analysis
  • Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Ask analyst for your customized sample: https://www.imarcgroup.com/request?type=reportid=21105flag=F

Browse more research report:
U.S. Self Storage Industry size is projected to exhibit a growth rate (CAGR) of 1.86% during 2024-2032.
U.S. Data Governance Industry size is projected to exhibit a growth rate (CAGR) of 21.36% during 2024-2032.
U.S. Orthobiologics Industry size is projected to exhibit a growth rate (CAGR) of 3.5% during 2024-2032.
U.S. Tooling Industry size is projected to exhibit a growth rate (CAGR) of 5.3% during 2024-2032.
U.S. Pates Industry size is projected to exhibit a growth rate (CAGR) of 3.3% during 2024-2032.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: [email protected] 

Tel No:(D) +91 120 433 0800 

United States: +1-631-791-1145

Read more
Comments